Non-invasive electron paramagnetic resonance imaging detects tumor redox imbalance induced by ferroptosis
- Kazuhiro Kato 1, Hironobu Yasui 1,2, Hideo Sato-Akaba 3, Miho C Emoto 4, Hirotada G Fujii 5, Maciej M Kmiec 6, Periannan Kuppusamy 6, Masaki Nagane 7, Tadashi Yamashita 7, Osamu Inanami 1
- Kazuhiro Kato 1, Hironobu Yasui 1,2, Hideo Sato-Akaba 3
- 1Laboratory of Radiation Biology, Department of Applied Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
- 2One Health Research Center, Hokkaido University, Sapporo, Japan.
- 3Department of Electrical and Electronic Engineering, Graduate School of Integrated Science and Technology, Shizuoka University, Hamamatsu, Japan.
- 4Department of Clinical Laboratory Science, School of Medical Technology, Health Sciences University of Hokkaido, Sapporo, Japan.
- 5Advanced Research Promotion Center, Health Sciences University of Hokkaido, Ishikari, Japan.
- 6Departments of Radiology and Radiation Oncology, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.
- 7Laboratory of Biochemistry, School of Veterinary Medicine, Azabu University, Sagamihara, Japan.
- 0Laboratory of Radiation Biology, Department of Applied Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Electron paramagnetic resonance imaging (EPRI) non-invasively detects ferroptosis, a cancer cell death mechanism. This novel redox imaging technique shows promise for in vivo cancer diagnostics and therapy monitoring.
Area Of Science
- Oncology
- Biomedical Imaging
- Cell Death Mechanisms
Background
- Ferroptosis, an iron-dependent form of cell death, and redox balance disruption are key cancer therapy targets.
- In vivo imaging of ferroptosis remains a significant challenge in cancer research and treatment.
Purpose Of The Study
- To investigate the application of electron paramagnetic resonance imaging (EPRI) for in vivo detection of ferroptosis.
- To correlate redox imaging data with established ferroptosis markers in tumor tissues.
Main Methods
- Utilized a portable electron paramagnetic resonance imaging (EPRI) device for non-invasive redox imaging of implanted tumors.
- Administered imidazole ketone erastin (IKE), a ferroptosis-inducing agent, to tumor-bearing subjects.
- Compared EPRI-derived redox maps with immunohistochemical images of 4-hydroxynonenal (4-HNE), a marker of lipid peroxidation.
Main Results
- Redox maps revealed changes in tumor redox status following IKE treatment.
- A negative correlation was observed between tumor reducing power (from EPRI) and 4-HNE-positive cell counts.
- Distinct distributions were noted on correlation maps between control and IKE-treated groups, indicating significant differences.
Conclusions
- Electron paramagnetic resonance imaging (EPRI) shows potential for non-invasive in vivo detection of ferroptosis.
- Redox imaging can reflect the ferroptosis-induced changes in tumor redox status.
- This technique may aid in monitoring ferroptosis during cancer therapy.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:16
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
01:24
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

